DT Investment Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$308K Hold
12,779
0.02% 122
2026
Q1
$359K Sell
12,779
-390
-3% -$10.4K 0.03% 113
2025
Q4
$328K Sell
13,169
-3,902
-23% -$98.4K 0.03% 113
2025
Q3
$435K Sell
17,071
-26,762
-61% -$661K 0.04% 105
2025
Q2
$1.06M Sell
43,833
-297
-0.7% -$6.93K 0.1% 81
2025
Q1
$1.12M Sell
44,130
-8,155
-16% -$213K 0.11% 81
2024
Q4
$1.39M Sell
52,285
-3,890
-7% -$106K 0.12% 75
2024
Q3
$1.63M Buy
56,175
+336
+0.6% +$9.8K 0.13% 72
2024
Q2
$1.56M Buy
55,839
+1,713
+3% +$47.2K 0.14% 69
2024
Q1
$1.5M Buy
54,126
+7,133
+15% +$198K 0.15% 64
2023
Q4
$1.27M Sell
46,993
-940
-2% -$28.4K 0.14% 69
2023
Q3
$1.59M Buy
47,933
+2,470
+5% +$87.3K 0.19% 56
2023
Q2
$1.62M Buy
45,463
+25
+0.1% +$973 0.18% 52
2023
Q1
$1.78M Buy
45,438
+2,189
+5% +$94.5K 0.22% 48
2022
Q4
$2.22M Buy
43,249
+5,403
+14% +$259K 0.29% 48
2022
Q3
$1.66M Sell
37,846
-5,266
-12% -$256K 0.27% 46
2022
Q2
$2.26M Buy
43,112
+6,956
+19% +$354K 0.34% 41
2022
Q1
$1.87M Buy
36,156
+5,433
+18% +$282K 0.24% 53
2021
Q4
$1.81M Sell
30,723
-4,121
-12% -$204K 0.24% 51
2021
Q3
$1.5M Buy
34,844
+10,377
+42% +$460K 0.2% 60
2021
Q2
$958K Buy
24,467
+1,961
+9% +$76.3K 0.13% 72
2021
Q1
$815K Buy
22,506
+3,623
+19% +$129K 0.12% 79
2020
Q4
$695K Sell
18,883
-9,407
-33% -$345K 0.11% 82
2020
Q3
$985K Sell
28,290
-2,790
-9% -$97.8K 0.14% 63
2020
Q2
$964K Buy
31,080
+7,636
+33% +$259K 0.12% 69
2020
Q1
$726K Sell
23,444
-122,459
-84% -$4.17M 0.12% 69
2019
Q4
$5.42M Buy
145,903
+17,413
+14% +$620K 0.5% 43
2019
Q3
$4.38M Buy
128,490
+10,675
+9% +$388K 0.57% 33
2019
Q2
$4.84M Buy
117,815
+2,327
+2% +$92.4K 0.67% 19
2019
Q1
$4.65M Buy
115,488
+238
+0.2% +$9.53K 0.65% 17
2018
Q4
$4.77M Sell
115,250
-2,597
-2% -$108K 0.76% 16
2018
Q3
$4.93M Buy
117,847
+7,101
+6% +$273K 0.71% 19
2018
Q2
$3.81M Buy
110,746
+8,094
+8% +$277K 0.59% 25
2018
Q1
$3.46M Buy
102,652
+13,394
+15% +$460K 0.54% 26
2017
Q4
$3.07M Buy
89,258
+8,264
+10% +$282K 0.49% 32
2017
Q3
$2.74M Buy
80,994
+32,386
+67% +$1.04M 0.46% 32
2017
Q2
$1.55M Buy
48,608
+7,932
+20% +$250K 0.3% 34
2017
Q1
$1.32M Buy
40,676
+6,286
+18% +$198K 0.3% 33
2016
Q4
$1.06M Buy
34,390
+1,827
+6% +$55.8K 0.27% 35
2016
Q3
$1.05M Buy
32,563
+1,298
+4% +$43.4K 0.27% 34
2016
Q2
$1.04M Buy
31,265
+5,020
+19% +$160K 0.28% 27
2016
Q1
$738K Sell
26,245
-405
-2% -$11.6K 0.21% 41
2015
Q4
$816K Buy
26,650
+338
+1% +$10.6K 0.24% 32
2015
Q3
$784K Sell
26,312
-10,293
-28% -$330K 0.24% 29
2015
Q2
$1.17M Buy
36,605
+10,486
+40% +$342K 0.3% 32
2015
Q1
$862K Buy
26,119
+1,384
+6% +$44K 0.26% 29
2014
Q4
$731K Sell
24,735
-2,758
-10% -$79.1K 0.23% 38
2014
Q3
$771K Buy
27,493
+8,333
+43% +$234K 0.25% 33
2014
Q2
$540K Buy
19,160
+2,498
+15% +$71.2K 0.19% 44
2014
Q1
$508K Sell
16,662
-7
-0% -$209 0.2% 40
2013
Q4
$484K Buy
16,669
+74
+0.4% +$2.15K 0.2% 42
2013
Q3
$452K Buy
16,595
+815
+5% +$22.2K 0.19% 38
2013
Q2
$419K Buy
+15,780
New +$436K 0.2% 36

Other funds holding PFE

DT Investment Partners's PFE Position: Q2 2026 in Review

DT Investment Partners held its Pfizer (PFE) position steady in Q2 2026 at 12,779 shares worth $308K. The position accounts for 0.02% of the portfolio, ranked #122.

DT Investment Partners first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.42M in Q4 2019. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • DT Investment Partners held 12,779 shares of Pfizer worth $308K as of Q2 2026.
  • DT Investment Partners left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.02% of DT Investment Partners's portfolio in Q2 2026, its #122 holding.
  • DT Investment Partners first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • DT Investment Partners's Pfizer position peaked at $5.42M in Q4 2019.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on DT Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.